Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
MPM Capital and NEA Lead $65 million Series a Preferred Round to Finance Spinout of TriVascular from Boston Scientific
April 18th, 2008
TriVascular2, a company newly formed to develop novel endovascular repair devices to treat abdominal aortic aneurysms (AAA), announced a $65 million Series A Preferred financing led by MPM Capital and New Enterprise Associates, Inc. (NEA) to acquire a subsidiary of Boston Scientific (NYSE: BSX) containing certain assets and intellectual property of its predecessor company TriVascular, Inc. MPM Capital is the largest venture capital investor dedicated solely to healthcare with $2.5 billion under management, and NEA is a leading diversified venture capital firm with $8.5 billion in committed capital. Joining MPM Capital and NEA as investors in the new privately held company are Delphi...
Source: Health Business Week (2008-04-18)
|
|
Advertisement |
|
|
|
